Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion type Assertion NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_head.
- NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion description "[For all patients, the rs12980275 A allele increased the odds for significant fibrosis (F ? 2) odds ratio (OR) = 1.68; p = 0.018) and more rapid fibrosis progression (FPR ? 0.075 fibrosis units/year) (OR = 1.64; p = 0.035), and decreased the odds for liver steatosis (OR = 0.61; p = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_provenance.
- NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion evidence source_evidence_literature NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_provenance.
- NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion SIO_000772 23103287 NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_provenance.
- NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion wasDerivedFrom befree-20150227 NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_provenance.
- NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_assertion wasGeneratedBy ECO_0000203 NP411269.RAhBuxEt_Dha-_RQtgI_jc_9cUXNmzeC63J5oavSJOz3g130_provenance.